Wuhan Xuqinxuan Biotechnology

Wuhan Xuqinxuan Biotechnology Co., Ltd. (Xuqinxuan Biology for short) is located in the Guoying Industry Building, No. 666, Shendun 4th Road, Donghu New Technology Development Zone, Wuhan City, Hubei Province, China. Xuqinxuan Biology is committed to the research and development, production, export in IVD reagents and pet rapid test kits. There is a hundred thousand clean workshop and strong R & D center. It has a professional team of 12 people, including 2 doctors, 3 masters and 7 undergraduates, and more than 15 years of experience in R & D and quality control.

We have obtained CE certification in 53 products, namely, Respiratory Diseases Testing Series (such as FLU A&B Antigen Test kit), Infectious Diseases Testing Series (e.g. H. pylori Stool Antigen Test Kit), Drug Testing Series (e.g. Morphine(MOP) Test Kit), Reproductive Health and Prenatal and Postnatal Care Series (e.g. Group A Streptococcus Test Kit), Inflammation Testing Series (e.g. Full C-Reactive Protein (Hypersensitive CRP + Conventional CRP) Test Kit(FIA), Cardiac Testing Series (e.g. Cardiac Troponin I (cTnI) Test Kit(FIA), Rheumatic Disease Testing Series (e.g. Rheumatoid factor Test Kit), Tumor Testing Series (such as Alpha-fetoprotein Test Kit), Growth and Development Series (25-hydroxyvitamin D (25-OH-VD) Test Kit(FIA)).

We also have obtained ISO13485 authoritative certification of Lloyd's UK. COVID - 19 reagents has passed the China customs inspection and quarantine, and is applying for product registration in Japan, Singapore, Malaysia, to meet the foreign demand for new epidemic detection. The products to be applied in China are further optimized on the basis of first-generation products, with better quality and stability, and able to meet the requirements of COVID-19 testing in China.

There is also a mature internatinal market in pet rapid test kits. Our featured products is CPV Ag, CDV Ag, CCV Ag, FPV Ag, FCV Ag, FHV Ag, CPV-CCV, etc.

It is planned to obtain medical device registration certificates for more than 25 products on colloidal gold platform, fluorescence chromatography quantitative platform, magnetic particle chemiluminescence platform and photochemistry platform in 2023, and achieve full coverage of the products in inflammation, myocardial infarction, gastrointestinal tract, kidney disease, hepatobiliary diseases, infectious diseases, drug abuse and food safety. The technology of fluorescence quantification POCT platform and magnetic particle chemiluminescence platform has reached the international advanced level.

Our company takes quality as the basis and technology as the guidance to develop IVD reagents and pet rapid test kits with market competitiveness, and provide global customers with the most satisfactory service.